LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Key Role Discovered for Enzyme in Preserving Essence of Stem Cells

By LabMedica International staff writers
Posted on 29 Aug 2012
Image: Mouse stem cells with both normally functioning copies of the Mof gene (left) have intact "stem-ness", that is lost in cells lacking one or both functional copies (middle and right) (Photo courtesy of Prof. Yali Dou’s laboratory, University of Michigan).
Image: Mouse stem cells with both normally functioning copies of the Mof gene (left) have intact "stem-ness", that is lost in cells lacking one or both functional copies (middle and right) (Photo courtesy of Prof. Yali Dou’s laboratory, University of Michigan).
A highly conserved yet unique acetyltransferase has now been shown to be essential in maintaining the self-renewal and pluripotent capacities of embryonic stem cells.

A team of scientists, primarily from the University of Michigan Medical School (Ann Arbor, MI, USA), have discovered that Mof, the only histone acetyltransferase known to be important in the functioning of non-differentiated embryonic stem cells (ESCs), is involved in regulating the core transcription mechanism in those cells by epigenetically marking chromatin to keep parts of the genome readily accessible. In ESCs, many areas of DNA are kept open for access, probably because they also need to produce many proteins that prevent differentiation. Once an ESC starts to differentiate, parts of the DNA close up and are no longer as accessible. Many scientific teams have studied this “selective silencing” and the factors that cause ESCs to start specializing by reading only certain genes. But few have looked at the crucial but little understood factors that facilitate broad-range DNA transcription to preserve “stem-ness”.

“If you think about stem cell biology, the self-renewal is one aspect that makes stem cells unique and powerful, and the differentiation is another,” says lead scientist Yali Dou, PhD and associate professor of pathology and biological chemistry. “People have looked a lot at differentiation to make cells useful for therapy in the future – but the stem cell itself is actually pretty fascinating.” Prof. Dou and her team have also reported on the protein WDR5 that places chromatin tags important during transcription, but Mof appears to control the process that actually allows cells to determine which genes to transcribe. “Mof marks the areas that need to stay open and maintains the potential to become anything,” Prof. Dou explains. The findings of the current extensive study, published on August 3, 2012, in the journal Cell Stem Cell, also include that ESC Mof-deletion mutants lose characteristic morphology, alkaline phosphatase (AP) staining, and differentiation potential. Furthermore, these mutants have aberrant expression of the core transcription factors Nanog, Oct4, and Sox2.

The new findings may also have particular importance for work on induced pluripotent stem cells (IPSCs), stem cells made from “adult” tissue. IPSC research holds promise for disease treatment as it could allow patients to be treated with stem cells made from their own tissue. But the current way of making IPSCs from tissue involves a process that uses a cancer-causing gene, a step that might give doctors and patients pause. Prof. Dou says that further work on Mof might make it possible to stop using this potentially harmful approach.

Related Links:

University of Michigan Health System



Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more